Thomas J. Herzfeld Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$61,880
-1.5%
4,0000.0%0.02%
-4.0%
Q2 2023$62,840
-4.7%
4,0000.0%0.02%
-7.4%
Q1 2023$65,920
+5.6%
4,0000.0%0.03%
+3.8%
Q4 2022$62,400
+20.0%
4,0000.0%0.03%
+18.2%
Q3 2022$52,000
-7.1%
4,0000.0%0.02%
-4.3%
Q2 2022$56,000
-1.8%
4,0000.0%0.02%
+9.5%
Q1 2022$57,000
+3.6%
4,0000.0%0.02%
+5.0%
Q4 2021$55,000
-16.7%
4,0000.0%0.02%
-31.0%
Q3 2021$66,000
-1.5%
4,0000.0%0.03%
+3.6%
Q2 2021$67,000
-8.2%
4,0000.0%0.03%
-15.2%
Q1 2021$73,0000.0%4,0000.0%0.03%
-2.9%
Q4 2020$73,000
+17.7%
4,0000.0%0.03%
-19.0%
Q3 2020$62,000
-15.1%
4,0000.0%0.04%
+16.7%
Q2 2020$73,000
+12.3%
4,000
-6.5%
0.04%
+2.9%
Q1 2020$65,000
-22.6%
4,2790.0%0.04%
+16.7%
Q4 2019$84,000
+13.5%
4,2790.0%0.03%
+11.1%
Q3 2019$74,000
-5.1%
4,279
-2.7%
0.03%
-10.0%
Q2 2019$78,000
-3.7%
4,396
+9.9%
0.03%0.0%
Q1 2019$81,000
+20.9%
4,0000.0%0.03%
+11.1%
Q4 2018$67,0004,0000.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders